INFLAMMATION AND IMPACT OF VINCRISTINE AND ENTEROSORPTION USE IN CHEMICALLY INDUCED COLON CARCER IN RATS

Authors

DOI:

https://doi.org/10.11603/ijmmr.2413-6077.2020.1.11503

Keywords:

inflammatory processes, proinflammatory interleukins, anti-inflammatory interleukins, AUT-M sorbent, cytostatic Vincristine

Abstract

Background. The increasing incidence of colon malignant tumors is one of the most urgent matters of contemporary medicine. In the study of carcinogenesis of the colon the attention is paid to the state of the body’s immune system and activation of inflammatory processes in experimental animals.

Objective. The aim of the study was to estimate the level of markers of inflammation in the serum of experimental animals with chemically induced carcinogenesis and their dynamics in case of administration of the cytostatic Vincristine secondary to AUT-M carbon enterosorbent.

Methods. The study was performed on white male rats. Animals were modeled for colon cancer by administration of 1.2-dimethylhydrazine hydrochloride at a dose of 7.2 mg/kg body weight for 30 weeks. AUT-M enterosorbent was administered intragastrically daily during 7 and 21 days after modeling of carcinogenesis at a dose of 1 ml of suspension (corresponding to 0.2 g of drug weight) per 100 g of animal body weight. The antitumor drug was administered to the animals with induced carcinogenesis intragastrically daily during 14 days at a dose of 0.23 mg/kg of body weight after a 21-day detoxification therapy. The activity of inflammatory processes was evaluated by the content of pro-inflammatory interleukin 6 and anti-inflammatory interleukin 4, C-reactive protein in the serum of experimental animals.

Results. It was established that introduction of 1.2-dimethylhydrazine hydrochloride in the rats caused changes in the cytokine profile and the content of C-reactive protein. In the affected animals an increase in the content of pro-inflammatory interleukin 6, C-reactive protein, as well as a decrease in the content of anti-inflammatory interleukin 4 was evidenced in all periods of the study. AUT-M enterosorbent contributed to normalization of these parameters. The cytostatic Vincristine had a negligible effect on development of inflammatory processes in the studied animals.

Conclusions. In cases of induced carcinogenesis, an imbalance in the content of pro- and anti-inflammatory cytokines, an increase in the content of acute-phase C-reactive protein was established. The positive effect of the cytostatic Vincristine secondary to a previous detoxification therapy with AUТ-M sorbent during a progressive development of inflammatory processes in the presence of modeled carcinogenesis was evidenced.

Author Biographies

O. I. Kachur, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

assistant professor, Department of General Chemistry, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

L. S. Fira, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

PhD, DSc, Professor, Head of the Department of Pharmacy of the Academic and Research Institute of Postgraduate Education, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

P. H. Lykhatskyi, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

PhD, DSc, Professor of the Department of Medical Biochemistry, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

References

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: Globocan estimates of inci­dence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424.

doi: 10.3322/caac.21492

Karmazina IS, Kulinich VA. Correlation analysis of protein metabolism indices at carcinogenesis and inflammation. Natural Almanac.2015;12: 112-8.

Zhang X, Liu S, Zhou Y. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis. Oncotarget. 2016 Sep 27;7(39):64371-79.

doi: 10.18632/oncotarget.11853

Gross D, Tolba R. Ethics in animal-based research. Eur. Surg. Res. 2015;55(1-2):43–57. doi: 10.1159/000377721

Zhou B, Shu B, Yang J, et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control, 2014;25(10): 1397-1405.

doi: 10.1007/s10552-014-0445-8

Madsen ML, Due H, Ejskaer N, et al. Aspects of Vincristine­induced neuropathy in hematologic malignancies: A systematic review. Cancer Chemother Pharmacol. 2019; 84:471–85.

doi: 10.1007/s00280-019-03884-5

Nikolaev VG, Sakhno LA, Snezhkova EA, Yushko LA. Саrbon adsorbents: achievements and perspec- tives. Experimental Oncology, 2011;1: 2-8.

Howell CA, Sandeman SR, Zheng Y, et al. New dextran coated activated carbons for medical use. Carbon N. Y. 2016;97:134-46.

doi:10.1016/j.carbon.20.15.09.042

Deryagina VP, Ryzhova NI, Razin AN. Expe­rimental study of the action of Lentinus edodes (Shii­take) on tumor growth in mouse models of trans­plantation and chemical carcinogenesis. Ros­sijskij onkologicheskij zhurnal. 2009(1):33-8.

Mikhalovsky SV., Sandeman SR, Howell CA, et al. Biomedical Applications of Carbon Adsorbents. In Novel Carbon Adsorbents,2012;21:639-69.

Rybolovlev YuR. Dosing of substances for mammals according to the constants of biological activity. Reports of the Academy of Sciences of the USSR, 1979; 247(6): 1513-6.

Kozhemiakin YuM, Khromov OS, Filonenko MA, et al.: Scientific and practical recommendations for the maintenance of laboratory animals and work with them. Kyiv - State Pharmacological Center of the Ministry of Health of Ukraine. Kiev, 2002.

Gaber W, Azkalany GS, Gheita TA, Mohey A, Sabry R. Clinical significance of serum interleukin-6 and− 174 G/C promoter polymorphism in Rheumatoid arthritis patients. The Egyptian Rheumatologist. 2013 Apr 1;35(2):107-13.

doi: 10.1016/j.ejr.2012.11.002

Alybaeva KM, Berdyyarova NA, Mukhamed-zhanova NK, et al. Analysis of the quantitative deter­mination of the level of C-reactive protein and pro­calcitonin in patients with infectious diseases. Bulle­tin of AGIUV. 2015;1-2:36-40.

Okeh U. Statistical problems in medical research. East. Afr. J. Public. Health. 2009;6 (1):1-7.

doi: 10.4314/eajph.v6i3.45762

Andreichyn SM, Lototska SV, Meretskyi VM. Changes in the indices of cytokine immunity in pa­tients with COPD when using enterosorption. Infec­tious Diseases, 2015; 3:44-7.

doi: 10.11603/mcch.2410-681x.2015.v17.i3.5063

Gaber W, Azkalany GS, Gheita TA, Mohey A, Sabry R. Clinical significance of serum interleukin-6 and 174 G/C promoter polymorphism in Rheumatoid arthritis patients. The Egyptian Rheumatologist. 2013 Apr 1;35(2):107-13.

doi: 10.1016/j.ejr.12.11.002

Godos J, Biondi A, Galvano F, et al. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies. World journal of gastroenterology. 2017 Mar 14;23(10):1909-19.

doi: 10.3748/wjg.v23.i10.1909

Kim MH, Moon HS, Kwon IS, et al. The in­cidence and risk factors of sessile serrated adenomas in left side colon cancer patients after curative surgery. Medicine. 2020 Jul 17;99(29).

doi: 10.1097/MD.0000000000020799

Downloads

Published

2020-11-11

How to Cite

Kachur, O. I., Fira, L. S., & Lykhatskyi, P. H. (2020). INFLAMMATION AND IMPACT OF VINCRISTINE AND ENTEROSORPTION USE IN CHEMICALLY INDUCED COLON CARCER IN RATS. International Journal of Medicine and Medical Research, 6(1), 74–80. https://doi.org/10.11603/ijmmr.2413-6077.2020.1.11503